|
Serna MJ, Rivera-Caravaca JM, Gonzalez-Conejero R, Esteve-Pastor MA, Valdés M, Vicente V, Lip GYH, Roldán V, Marín F. Pharmacogenetics of vitamin K antagonists and bleeding risk prediction in atrial fibrillation. Eur J Clin Invest. 2018 Jun;48(6):e12929. doi: 10.1111/eci.12929. Epub 2018 Apr 17. PubMed PMID: 29577257.
AÑO: 2018; IF: 5.722
|
29577257
|
Rivera-Caravaca JM, Roldán V, Romera M, Esteve-Pastor MA, Valdés M, Lip GYH, Vicente V, Marín F. Soluble Fibrin Monomer Complex and Prediction of Cardiovascular Events in Atrial Fibrillation: The Observational Murcia Atrial Fibrillation Project. J Gen Intern Med. 2018 Jun;33(6):847-854. doi: 10.1007/s11606-017-4279-4. Epub 2018 Mar 22. PubMed PMID: 29569024; PubMed Central PMCID: PMC5975135.
AÑO: 2018; IF: 6.473
|
|
Pastori D, Rivera-Caravaca JM, Esteve-Pastor MA, Roldán V, Marín F, Pignatelli P, Violi F, Lip GYH. Comparison of the 2MACE and TIMI-AF Scores for Composite Clinical Outcomes in Anticoagulated Atrial Fibrillation Patients. Circ J. 2018 Apr 25;82(5):1286-1292. doi: 10.1253/circj.CJ-17-1318. Epub 2018 Mar 16. PubMed PMID: 29553090.
AÑO: 2018; IF: 3.025
|
|
Esteve-Pastor MA, Rivera-Caravaca JM, Roldán-Rabadán I, Roldán V, Muñiz J, Raña-Míguez P, Ruiz-Ortiz M, Cequier Á, Bertomeu-Martínez V, Badimón L, Anguita M, Lip GYH, Marín F; FANTASIIA Study Investigators. Relation of Renal Dysfunction to Quality of Anticoagulation Control in Patients with Atrial Fibrillation: The FANTASIIA Registry. Thromb Haemost. 2018 Feb;118(2):279-287. doi: 10.1160/TH17-06-0416. Epub 2018 Jan 29. PubMed PMID: 29443369.
AÑO: 2018; IF: 4.733
|
|
Rivera-Caravaca JM, Roldán V, Esteve-Pastor MA, Valdés M, Vicente V, Marín F, Lip GYH. Prediction of long-term net clinical outcomes using the TIMI-AF score: Comparison with CHA(2)DS(2)-VASc and HAS-BLED. Am Heart J. 2018 Mar;197:27-34. doi: 10.1016/j.ahj.2017.11.004. Epub 2017 Nov 10. PubMed PMID: 29447781.
AÑO: 2018; IF: 4.023
|